Provided by Tiger Trade Technology Pte. Ltd.

Artelo Biosciences, Inc.

0.0056
0.0000
Volume:- -
Turnover:- -
Market Cap:18.75K
PE:0.00
High:0.0056
Open:0.0056
Low:0.0056
Close:0.0056
52wk High:0.0056
52wk Low:0.0056
Shares:3.35M
Float Shares:2.35M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1338
EPS(LYR):-1.5020
ROE:943.26%
ROA:-314.86%
PB:--
PE(LYR):0.00

Loading ...

Company Profile

Company Name:
Artelo Biosciences, Inc.
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Its product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment of inflammatory bowel disease and post-traumatic stress disorder (PTSD); and ART26.12, a fatty acid binding protein 5 inhibitor for treating breast and prostate cancer, neuropathic and nociceptive pain, and anxiety disorders, including PTSD. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.